Cargando…

Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational study

OBJECTIVES: Conventional polyethoxylated castor oil (PCO)-based paclitaxel is associated with major adverse drug reactions (ADRs). Nanoxel, a nanoparticle-based formulation, may improve its tolerability by removing the need for PCO vehicle, and also permit its use in a higher dose. We conducted inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brahmachari, Ballari, Hazra, Avijit, Majumdar, Anup
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081448/ https://www.ncbi.nlm.nih.gov/pubmed/21572644 http://dx.doi.org/10.4103/0253-7613.77341

Ejemplares similares

Variation of adverse drug reaction profile of platinum-based chemotherapy with body mass index in patients with solid tumors: An observational study
por: Chatterjee, Dattatreyo, et al.
Publicado: (2014)

Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
por: Naganuma, Misa, et al.
Publicado: (2019)

Adaptive design – An innovative tool in drug development
por: Brahmachari, Ballari, et al.
Publicado: (2011)

Cutaneous adverse drug reaction profile in a tertiary care out patient setting in Eastern India
por: Saha, Abanti, et al.
Publicado: (2012)

Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital
por: Sengupta, Gairik, et al.
Publicado: (2011)

Myopathy induced by statin-ezetimibe combination: Evaluation of potential risk factors
por: Brahmachari, Ballari, et al.
Publicado: (2015)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
por: Gupta, Arunima, et al.
Publicado: (2014)

Pharmacovigilance for clinical trials in India: Current practice and areas for reform
por: Brahmachari, Ballari, et al.
Publicado: (2011)

Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections
por: Dey, Sudipta Kumar, et al.
Publicado: (2015)

Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush
por: Selcuk, Ali, et al.
Publicado: (2022)

Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
por: Fukuda, Akiho, et al.
Publicado: (2017)

Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp
por: Zhao, Minzhi, et al.
Publicado: (2015)

Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: A randomized controlled trial
por: Maroo, Niteeka, et al.
Publicado: (2013)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
por: Lazzaro, Carlo, et al.
Publicado: (2013)

Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: A randomized controlled trial
por: Pande, Satabdi, et al.
Publicado: (2014)

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
por: Hamaguchi, T, et al.
Publicado: (2005)

Adverse drug reaction profile of oseltamivir in Indian population: A prospective observational study
por: Anovadiya, Ashish P., et al.
Publicado: (2011)

Rapid and Sensitive Liquid Chromatographic Method for Determination of Paclitaxel from Parenteral Formulation and Nanoparticles
por: Kollipara, S., et al.
Publicado: (2010)

Adverse drug reaction profile of oseltamivir in children
por: Dalvi, Prashant S., et al.
Publicado: (2011)

Evaluation of antiemetic effect of intravenous palonosetron versus intravenous ondansetron in laparoscopic cholecystectomy: A randomized controlled trial
por: Laha, Baisakhi, et al.
Publicado: (2013)

Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study
por: Chatterjee, Dattatreyo, et al.
Publicado: (2016)

Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane
por: Feng, Zhongling, et al.
Publicado: (2009)

Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation
por: WANG, HONGBO, et al.
Publicado: (2013)

Photodermatitis in a woman with infiltrating intraductal breast carcinoma: An uncommon adverse cutaneous drug reaction of paclitaxel revisited
por: Mahajan, Vikram K., et al.
Publicado: (2020)

Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department
por: Das, Manisha, et al.
Publicado: (2017)

An Observational Study on Response to Growth Hormone Therapy in Indian Patients of Short Stature with Special Emphasis on Biochemical Parameters and Bone Biomarkers
por: Roy, Ritam, et al.
Publicado: (2023)

Levothyroxine: Conventional and Novel Drug Delivery Formulations
por: Liu, Hanqing, et al.
Publicado: (2022)

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation
por: Hamaguchi, T, et al.
Publicado: (2007)

Self-Assembly of pH-Labile Polymer Nanoparticles for Paclitaxel Prodrug Delivery: Formulation, Characterization, and Evaluation
por: Levit, Shani L., et al.
Publicado: (2020)

Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia
por: Maity, Somnath, et al.
Publicado: (2014)

Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer: A retrospective observational study
por: Oi, Hajime, et al.
Publicado: (2022)

Adverse Drug Reactions for CAM and Conventional Drugs Detected in a Network of Physicians Certified to Prescribe CAM Drugs
por: Tabali, Manuela, et al.
Publicado: (2012)

An observational study on acute poisoning in a tertiary care hospital in West Bengal, India
por: Chatterjee, Suparna, et al.
Publicado: (2020)

Adverse drug reaction profile of daily regimen antituberculosis treatment
por: Sankar, K. N. Hari, et al.
Publicado: (2022)

Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers
por: Chatterjee, Subhrangsu, et al.
Publicado: (2019)

Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro
por: Leiva, María Carmen, et al.
Publicado: (2017)

An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulation
por: Nakamura, Iwao, et al.
Publicado: (2017)

Treatment of cephalic arch stenosis in dysfunctional arteriovenous fistulas with paclitaxel-coated versus conventional balloon angioplasty
por: Tng, Ren Kwang A., et al.
Publicado: (2021)

Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
por: de Leon, Maria C.B., et al.
Publicado: (2013)

Nanoparticle albumin-bound paclitaxel versus solvent-based paclitaxel in breast cancer: A protocol for systemic review and meta-analysis
por: Li, Bingxue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o6fpre22ulsdn588j6rbd68s35